Anna M Hood1, Charles T Quinn2, Christopher D King3, Lisa M Shook4, James L Peugh5, Lori E Crosby5. 1. Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, United Kingdom; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. 2. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; Cancer and Blood Diseases Institute, Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. 3. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; Pain Research Center, Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. 4. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; Cancer and Blood Diseases Institute, Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. Electronic address: a.hood@ucl.ac.uk. 5. Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, United Kingdom; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States; Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Abstract
OBJECTIVES: Sickle cell disease (SCD) is the most prevalent inherited hematological disorder and affects 100,000 individuals in the United States. Pain is the most common cause of emergency department (ED) visits in the SCD population, which profoundly affects quality of life. Vitamin D supplementation is a potential target for reducing pain. Thus, the goal of the present study was to identify the prevalence of vitamin D deficiency and explore the relationship between vitamin D supplementation and ED visits in pediatric patients with SCD. DESIGN: We conducted a retrospective chart review of 110 patients with SCD aged 8-16 years who had at least one ED visit for SCD pain during the 6-year study period. Patients were categorized into three vitamin D supplementation groups: patients who did not receive supplementation, patients supplemented with 25-hydroxyvitamin D levels (< 30 ng/mL), and patients supplemented with at least one sufficient 25-hydroxyvitamin D level (≥ 30 ng/mL). RESULTS: Overall, 45 % of patients were vitamin D deficient. Only 20 % of patients had sufficient vitamin D levels. This number increased to 55 % when examining only patients who did not receive vitamin D supplementation. For patients supplemented with vitamin D, the number of ED visits was significantly lower after they reached the sufficient range (≥ 30 ng/mL), p = 0.03. CONCLUSIONS: Our findings indicate that reductions in the number of pain-related ED visits may be achieved by normalizing 25-hydroxyvitamin D levels with supplementation. In addition, findings highlight the need for screening and vitamin D supplementation being incorporated into routine care for pediatric patients with SCD.
OBJECTIVES:Sickle cell disease (SCD) is the most prevalent inherited hematological disorder and affects 100,000 individuals in the United States. Pain is the most common cause of emergency department (ED) visits in the SCD population, which profoundly affects quality of life. Vitamin D supplementation is a potential target for reducing pain. Thus, the goal of the present study was to identify the prevalence of vitamin Ddeficiency and explore the relationship between vitamin D supplementation and ED visits in pediatric patients with SCD. DESIGN: We conducted a retrospective chart review of 110 patients with SCD aged 8-16 years who had at least one ED visit for SCD pain during the 6-year study period. Patients were categorized into three vitamin D supplementation groups: patients who did not receive supplementation, patients supplemented with 25-hydroxyvitamin D levels (< 30 ng/mL), and patients supplemented with at least one sufficient 25-hydroxyvitamin D level (≥ 30 ng/mL). RESULTS: Overall, 45 % of patients were vitamin D deficient. Only 20 % of patients had sufficient vitamin D levels. This number increased to 55 % when examining only patients who did not receive vitamin D supplementation. For patients supplemented with vitamin D, the number of ED visits was significantly lower after they reached the sufficient range (≥ 30 ng/mL), p = 0.03. CONCLUSIONS: Our findings indicate that reductions in the number of pain-related ED visits may be achieved by normalizing 25-hydroxyvitamin D levels with supplementation. In addition, findings highlight the need for screening and vitamin D supplementation being incorporated into routine care for pediatric patients with SCD.
Authors: Samuel A Adegoke; Josefina A P Braga; Adekunle D Adekile; Maria S Figueiredo Journal: J Pediatr Hematol Oncol Date: 2018-05 Impact factor: 1.289
Authors: David J Martyres; Abi Vijenthira; Nick Barrowman; Sydney Harris-Janz; Christine Chretien; Robert J Klaassen Journal: Pediatr Blood Cancer Date: 2016-02-08 Impact factor: 3.167
Authors: V Mandese; E Bigi; P Bruzzi; G Palazzi; B Predieri; L Lucaccioni; M Cellini; L Iughetti Journal: BMC Pediatr Date: 2019-02-11 Impact factor: 2.125
Authors: Deepika S Darbari; Zhengyuan Wang; Minjung Kwak; Mariana Hildesheim; James Nichols; Darlene Allen; Catherine Seamon; Marlene Peters-Lawrence; Anna Conrey; Mary K Hall; Gregory J Kato; James G Taylor Journal: PLoS One Date: 2013-11-05 Impact factor: 3.240
Authors: Rhiannon R Penkert; Melissa Azul; Robert E Sealy; Bart G Jones; Jola Dowdy; Randall T Hayden; Li Tang; A Catharine Ross; Jane S Hankins; Julia L Hurwitz Journal: Nutrients Date: 2022-08-19 Impact factor: 6.706